Finance

Lists
INAF:IDX
Indofarma Tbk PT
IDRĀ 126.00
0.00%
(0.00) 1D
Jul 1, 2:55:02ā€ÆPM GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for INAF...
Mkt. cap
396.71B
Volume
0.00
P/E ratio
18.15
52-wk high
IDRĀ 126
52-wk low
IDRĀ 126
EPS
IDRĀ 7
Shares outstanding
3.10B
No. of employees
39
Mkt. cap
396.71B
Volume
0.00
P/E ratio
18.15
52-wk high
IDRĀ 126
52-wk low
IDRĀ 126
EPS
IDRĀ 7
Shares outstanding
3.10B
No. of employees
39
News stories
From web sources and news partners
About Indofarma Tbk PT
CEO-
Employees39
Founded1918
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteindofarma.id
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
17.82B
53.33B
25.72B
54.99B
Cost of goods sold
22.60B
49.55B
23.00B
47.18B
Cost of revenue
22.60B
49.55B
23.00B
47.18B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.25B
5.93B
5.92B
8.60B
Operating expense
77.15B
5.93B
5.77B
10.35B
Total operating expenses
99.75B
55.48B
28.77B
57.54B
Operating income
-81.94B
-2.16B
-3.05B
-2.55B
Other non operating income
-1.00
-
-
-
EBT including unusual items
47.04B
-7.60B
-25.57B
5.26B
EBT excluding unusual items
-111.28B
-7.60B
-6.94B
-13.37B
Income tax expense
-2.06B
-21.03M
-21.03M
-316.42M
Effective tax rate
-4.37%
0.28%
0.08%
-6.02%
Other operating expenses
72.91B
20.01K
-148.55M
1.76B
Net income
49.10B
-7.58B
-25.55B
5.57B
Net profit margin
275.62%
-14.22%
-99.34%
10.14%
Earnings per share
-
-
-
-
Interest and investment income
20.72M
12.10M
8.94M
-
Interest expense
-21.36B
-4.42B
-4.35B
-11.57B
Net interest expenses
-21.34B
-4.41B
-4.34B
-11.57B
Depreciation and amortization charges
-
-
-
-
EBITDA
-78.45B
918.81M
14.87M
522.05M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps